
Why CDMOs Should Consider Value-Based Pricing
Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.

Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.










The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.











Digitalization is a very important topic not only in the chemical industry as a whole, but also in chemical distribution.












